There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bioventus (BVS) and Elanco Animal Health (ELAN) with bullish sentiments.Meet Samuel – Your Personal Investing ProphetStart a conversation with TipRanks’ trusted, data-backed investment intelligence
Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Bioventus (BVS)
In a report issued on May 22, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Bioventus. The company’s shares closed last Friday at $9.28.
According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of 36.4% and a 57.8% success rate. Knickerbocker covers the Healthcare sector, focusing on stocks such as Phathom Pharmaceuticals, Xtant Medical Holdings, and Fennec Pharmaceuticals.
